What is the price of Hancock Jaffe Laboratories (HJLI)

The price of Hancock Jaffe Laboratories (HJLI) is $10.38

What is the market cap of Hancock Jaffe Laboratories (HJLI)

The market cap of Hancock Jaffe Laboratories (HJLI) is $4.55M

Hancock Jaffe Laboratories (HJLI) EPS

Hancock Jaffe Laboratories, Inc. is a medical device company in its developmental stage, specializing in creating advanced tissue-based and biologic solutions. These innovations are engineered to either sustain or significantly enhance the lives of patients afflicted with cardiovascular, peripheral arterial, and venous diseases, as well as end-stage renal disease (ESRD). The firm, headquartered in Irvine, California, maintains a dedicated team of nine full-time employees. Among its key initiatives, the company is actively developing implantable bioprosthetic devices for cardiovascular applications. This includes the Bioprosthetic Heart Valve (BHV), a swine-derived heart valve designed to mimic the function of a native heart valve and provide superior performance compared to current prosthetic options. Furthermore, the company is developing a Venous Valve, another bioprosthetic device sourced from pig tissue. This valve is specifically designed for individuals suffering from chronic venous insufficiency (CVI) in the lower limbs, a condition frequently resulting from damage to leg vein valves after the formation of deep venous blood clots.

Year	EPS	Change
Not enough data for the provided dates.

Year

EPS

Change

Not enough data for the provided dates.

Company	EPS	EPS Difference	Country
Abbott Laboratories ABT.US	$3.11	-	US
Stryker Corporation SYK.US	$9.73	-	US
Medtronic plc MDT.US	$3.59	-	IE
Boston Scientific Corporation BSX.US	$2.48	-	US
Edwards Lifesciences Corporation EW.US	$1.74	-	US

Company

EPS

EPS Difference

Country